When Antidepressants Haven't Been Enough
Treatment-resistant depression affects millions of people who do everything right: they try multiple medications, attend therapy, and still can't find lasting relief. Ketamine infusion therapy works through a completely different mechanism, and for many patients, it finally delivers results.
Individual results vary. Response rates based on published clinical literature.
More Than Sadness — A Medical Condition
Depression is one of the most common and most debilitating mental health conditions in the world. It goes far beyond feeling sad. For many people, it involves a profound loss of motivation, pleasure, energy, and hope that persists for months or years.
Major Depressive Disorder (MDD) affects approximately 21 million adults in the US. Treatment-Resistant Depression (TRD), typically defined as failing to respond adequately to at least two different antidepressants, affects roughly one-third of those patients.
TRD is not a character failing. It often reflects underlying differences in brain chemistry that standard medications simply aren't equipped to address. That's where ketamine comes in.
Common Symptoms Ketamine May Help
- ✓ Persistent low mood or emptiness
- ✓ Loss of interest in activities once enjoyed
- ✓ Fatigue and low energy
- ✓ Difficulty concentrating or making decisions
- ✓ Sleep disturbances (too much or too little)
- ✓ Feelings of worthlessness or hopelessness
- ✓ Suicidal thoughts or passive ideation
Ketamine is particularly studied for patients who have not responded to 2 or more antidepressant trials.
How Ketamine May Help Depression
Ketamine works through a fundamentally different pathway than SSRIs, SNRIs, or other antidepressants.
Glutamate, Not Serotonin
Most antidepressants target serotonin or norepinephrine. Ketamine blocks NMDA receptors in the glutamate system (the brain's main excitatory pathway), producing effects that operate independently of the serotonin system.
Rapid BDNF Surge
Preclinical research demonstrates that ketamine rapidly increases Brain-Derived Neurotrophic Factor (BDNF), a protein essential for growing new neural connections. This is thought to help "regrow" synaptic pathways that chronic depression can atrophy over time, though direct evidence in humans is still being established.
Synaptic Restoration
Chronic depression is associated with reduced synaptic density in the prefrontal cortex. Recent human PET imaging studies suggest ketamine may help restore this density, which could explain why many patients feel a "lifting" of depression sooner than with conventional medications.
Neuroplasticity Window
The hours and days after an infusion represent a heightened window of neuroplasticity. Many patients find this an ideal time to engage in therapy, journaling, or other therapeutic work, reinforcing the gains from treatment.
What the Research Shows
Ketamine for depression is among the most studied applications of this treatment. The evidence base is robust and growing.
- A landmark 2000 study in Biological Psychiatry (Berman et al.) found that a single IV ketamine infusion produced rapid antidepressant effects in patients with depression, with results that emerged within hours. A 2006 randomized trial in Archives of General Psychiatry (Zarate et al.) replicated these findings specifically in TRD patients.
- Meta-analyses of randomized controlled trials consistently show response rates of 50–70% in treatment-resistant patients, far exceeding what's seen with additional antidepressant trials.
- The FDA approval of esketamine (Spravato®) for TRD in 2019 validated the glutamate mechanism, though IV ketamine remains the clinical gold standard for speed and efficacy.
- Research also supports ketamine's rapid anti-suicidal effects (Wilkinson et al., 2018), a critical benefit for patients in acute distress.
Clinical evidence supports ketamine as a promising option for TRD. Individual results vary, and ketamine is not appropriate for everyone. Our providers will help determine if it's right for you.
IV Ketamine vs. Spravato® (Esketamine)
Is Ketamine Right for Your Depression?
You may be a good candidate if:
- ✓ You've tried 2+ antidepressants without adequate relief
- ✓ You've been diagnosed with MDD or TRD
- ✓ Depression significantly impacts your daily functioning
- ✓ You're medically stable and cleared by a provider
- ✓ You can commit to a series of 4–6 infusions
Additional screening is needed if you have:
- – A history of psychosis or schizophrenia
- – Uncontrolled high blood pressure
- – Active substance use disorder
- – Certain thyroid conditions
A free consultation helps us understand your full history and determine fit.
Take the First Step Toward Relief
Your consultation is free, confidential, and carries no obligation. Let's find out if ketamine therapy is right for you.